Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer's disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study shows persisting cognitive benefits and reduced mortality for up to five years after diagnosis.
from Healthy Aging News -- ScienceDaily https://ift.tt/3w1SpVM
No comments:
Post a Comment